Biotech Values

[DewDiligence]

RVNC—That’s the same argument some people promulgated against AGN’s Voluma dermal filler, which lasts about twice as long as other dermal filers.

It’s a bogus argument.

If a better product is available in the market, injectors can’t afford to not offer it. If they don’t, patients will find someone who will.